Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Siva-1 negatively regulates NF-κB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD)

Abstract

Ligation of TCRs on stimulated T cells leads to activation-induced cell death (AICD) resulting in the downregulation of immune responses, a process essential for T-cell homeostasis. In this study, using transformed T-cell lines such as Jurkat and Do11.10 as cellular models of TCR-mediated AICD, we have demonstrated that the proapoptotic protein Siva-1 is required for TCR-induced apoptosis. Knockdown of Siva-1 rendered T cells specifically resistant to anti-CD3 but not Fas-induced apoptosis. Further, we observed that in Siva-1 knockout Jurkat cells, TCR-mediated activation of the canonical and non-canonical limbs of the NF-κB pathway are significantly enhanced as reflected by elevated nuclear levels of p65 and RelB, respectively. In addition, loss of endogenous Siva-1 also resulted in the enhanced expression of NF-κB- responsive anti-apoptotic genes such as Bcl-xL and c-FLIP. Interestingly, the c-FLIPshort was detected only in TCR-ligated Siva-1 knockdown Jurkat cells. These results demonstrate a significant role for endogenous Siva-1, through its inhibitory effect on NF-κB activity, in TCR-mediated AICD with implications in peripheral tolerance, T-cell homeostasis and cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H et al. (2002). Nature 415: 922–926.

  • Brummelkamp TR, Bernards R, Agami R . (2002). Science 296: 550–553.

  • Cao C, Ren X, Kharbanda S, Koleske A, Prasad KVS, Kufe D . (2001). J Biol Chem 276: 11465–11468.

  • Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Prasad KVS . (2005). Cancer Res 12: 5301–5309.

  • Chu F, Borthakur A, Sun X, Barkinge J, Gudi R, Hawkins S et al. (2004). Apoptosis 9: 83–95.

  • Ghosh S, Karin M . (2002). Cell suppl 109: S81–S96.

  • Green DR, Droin N, Pinkoski M . (2003). Immunol Rev 193: 70–81.

  • Hauer J, Puschner S, Ramakrishnan P, Simon U, Bongers M, Federle C et al. (2005). Proc Natl Acad Sci USA 102: 2874–2879.

  • Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T . (2000). J Virol 74: 4284–4290.

  • Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P . (2002). Curr Opin Immunol 14: 354–359.

  • Li Y, Sedwick CE, Hu J, Altman A . (2005). J Biol Chem 280: 1217–1223.

  • Muller MM, Schreiber E, Schaffner W, Matthias P . (1989). Nucleic Acids Res 17: 6420.

  • Nossal GJ . (1994). Cell 76: 229–239.

  • Prasad KV, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S et al. (1997). Proc Natl Acad Sci USA 94: 6346–6351.

  • Schmitz I, Weyd H, Krueger A, Baumann S, Fas SC, Krammer PH et al. (2004). J Immunol 172: 2194–2200.

  • Spinicelli S, Nocentini G, Ronchetti S, Krausz LT, Bianchini R, Riccardi C . (2002). Cell Death Differ 9: 1382–1384.

  • Wan YY, DeGregori J . (2003). Immunity 18: 331–343.

  • Xiao N, Chunlei Z, Rakhashandra T, Madeleine D . (2005). Lymphoma J Invest Dermatol 124: 741–750.

  • Xue L, Chu F, Cheng Y, Sun X, Borthakur A, Ramarao M et al. (2002). Proc Natl Acad Sci USA 99: 6925–6930.

  • Yoon Y, Ao Z, Cheng Y, Schlossman SF, Prasad KV . (1999). Oncogene 18: 7174–7179.

Download references

Acknowledgements

We thank Drs B. Prabhakar and C. Vasu (UIC) for helpful comments and Drs T. Hope (North Western University) and B. Cullen (Duke University) for providing the lentiviral siRNA vector. The anti-CD3 antibodies (OKT3 and 2C11) and anti-FLIP (NF-6) antibody were kind gifts from Drs Gordon Freeman (Harvard University) and Marcus Peter (University of Chicago), respectively.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K V S Prasad.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gudi, R., Barkinge, J., Hawkins, S. et al. Siva-1 negatively regulates NF-κB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD). Oncogene 25, 3458–3462 (2006). https://doi.org/10.1038/sj.onc.1209381

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209381

Keywords

This article is cited by

Search

Quick links